Sonio, a pioneering MedTech company specializing in women’s and children’s health, has entered a transformative chapter in its journey. With the official approval of its acquisition by Samsung, Sonio is set to accelerate its global expansion and innovation in maternal healthcare. This strategic acquisition, approved by the French Ministry of the Economy and Finance, comes at a critical time for Sonio, following its second wave of FDA clearances and successful deployment of AI-powered solutions across multiple U.S. sites.

A Strategic Acquisition at a Pivotal Moment

Founded in 2020, Sonio has rapidly gained recognition for its cutting-edge technology aimed at improving the health outcomes of women and children. The acquisition by Samsung represents a significant milestone in Sonio’s mission to revolutionize maternal and child healthcare. The collaboration with Samsung Medison, a subsidiary of Samsung Electronics focused on medical devices, will enable Sonio to leverage Samsung’s engineering expertise and global reach, accelerating the development and distribution of innovative healthcare solutions worldwide.

Advancing AI-Powered Healthcare Solutions

Sonio’s AI-driven reporting and workflow solutions for obstetrics and gynecology have already made a significant impact in the U.S. market, enhancing the quality and efficiency of ultrasound exams. The company’s technology assists clinicians in evaluating and documenting ultrasound exams, providing real-time guidance and quality assurance that is increasingly critical in the face of global healthcare workforce shortages. With Samsung’s backing, Sonio plans to further enhance its AI technologies, aiming to introduce next-generation solutions that will set new standards in maternal healthcare.

Commitment to Global Health and Innovation

Under the continued leadership of CEO and co-founder Cécile Brosset, Sonio remains committed to its mission of providing equal access to high-quality maternal healthcare globally. The company will maintain its independence while benefiting from the strategic partnership with Samsung Medison. This collaboration is expected to drive significant advancements in AI-enhanced ultrasound technologies, with a focus on improving patient care and expanding access to underserved regions.

The acquisition of Sonio by Samsung marks a new era of growth and innovation for the French MedTech company. By combining Sonio’s AI-powered healthcare solutions with Samsung’s engineering prowess, the partnership aims to revolutionize maternal and child healthcare globally. As Sonio continues to operate independently, its commitment to enhancing healthcare quality and accessibility remains unwavering, promising a brighter future for women and children worldwide.